Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

RegMed Daily, Closing Bell, 10/28/11, big trading on headline risk

End of Day, Cause and Effect …


No one is LONG … over these weekends … the enthusiasm over the … latest rescue effort … might (a big hope) last longer than the optimism … than slowly fade away. Small caps (RegMed companies) confirmed the market’s bullish trend when the Russell 2000 closed … above a key resistance level. The Russell 2000, up 5.3%, outpaced the market’s overall gains and was the last of the 4 major stock market indices to close above resistance.

I do think or nor doubt … this optimism is real and I do think we’ve started to see a (slight)  turn here. I am never …  surprised that markets  … pull back a bit (daily), but this time … dips should be purchased. I have been seeing signs for about a month now but, RegMed earnings season (4-5 companies announcing next week) should articulate the next few months and preface Q1/12.  


Closing Bell: The NASDAQ closed DOWN -1.48 (-0.05%) to 2,737.15. The Dow closed UP +24.22 (+0.20%) to 12,232.77. The DOW is back over 12K .. hu – ah!


Who’s up … at the close and any … whys:

Athersys (NASDAQ:ATHX) +$0.10 <+6.94%>to $1.54; BioMimetic (NASDAQ:BMTI) +0.02 <+0.55%> to $3.67;Dendreon (NASDAQ:DNDN) +0.35 <+3.20%> to $11.29; ImmunoCellular (OTC BB:IMUC) +$0.07 <5.26%> to $1.40;   ReNeuron (RENE.LON) +$0.24 <+5.69%> to $4.49; Tengion (TNGN) +$0.026 <+5.27%> to +$0.519 and ThermoGenesis (NASDAQ:KOOL) +$0.04 <3.31%> to $1.25.


**<Small Volumes>